Recently, Ercu et al., (2022) reported that mutant phosphodiesterase 3A (PDE3A) led to aberrant phosphorylation and altered adrenergic signaling pathway, which resulted in protection against hypertension-induced cardiac damage in hearts. The gene discussed is PDE3A; the disease is hypertensive disorder.